Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

1925 Results

Guidelines and Advice

Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer

Status: Current
ID: GL 27-2
Version: 2

Feb 2021

Cancer facts

Percentage of Women Late for Cervical Screening Varies Geographically

Dec 2016

Survivorship Program

Cancer Screening During COVID-19: Message for Healthcare Providers

Cancer facts

Diesel Engine Exhaust Causes Almost 200 Work-related Lung Cancers Annually in Ontario

Jan 2015

What you need to know about COVID-19 vaccines: Information for people with cancer

Guidelines and Advice

An Endorsement of the 2018 Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Status: In-Review
ID: 3-22
Version: N/A

Apr 2020

Updated Reference Population, Age-Standardized Rates

Guidelines and Advice

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Status: Current
ID: GL END 5-7
Version: 3

Nov 2021

Guidelines and Advice

The Role of IMRT in Head and Neck Cancer

Status: Archived
ID: 21-3-3

Jan 2011

Biosimilars – What You Need to Know – for Providers

Guidelines and Advice

Plerixafor for Autologous Hematopoietic Stem Cell Mobilization and Transplantation for Patients in Ontario

Status: Current
ID: SCT-7

Sep 2015

Pages